Phone: 86-29-89601602
E-mail: sales28@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
What Does Semaglutide Do For Weight Loss ?
What Does Semaglutide Do For Weight Loss ?
Oral Somalutide, developed and manufactured by Novo Nordisk and also known as Semaglutide, is a glucagon-like peptide 1 (GLP-1) receptor agonist that was approved for marketing by the US FDA in 2019. Somaglutide has beneficial effects on a variety of vital organs, including the pancreas, heart and liver.
Semeglutide is a new GLP-1 analogue that is injected subcutaneously once a week. Today, many people are using Semaglutide Powder for weight loss and the results are impressive. Successful weight loss has been achieved and Semaglutide Weight Loss has shown the ability to help patients lose weight.
Somalutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes.
So, how is Semaglutide taken correctly?
Semeglutide is easy to take orally and has low bioavailability, freeing patients from the inconvenience of injections. Semeglutide is started at 3mg once a day for 30 days. 3mg Semeglutide doses are used to start therapy and are not effective for blood glucose control. It is not recommended to take two 7mg tablets of Semeglutide to achieve the 14 mg dose. After 30 days of taking the 3 mg dose, the dose is increased to 7 mg once daily. If additional blood glucose control is required, after taking a 7 mg dose for at least 30 days, the dose may be increased to 14 mg once daily at a time.
So what are the precautions and side effects of Semeglutide ?
Patients should be aware during treatment with Semeglutide that: patients with a personal or family history of medullary thyroid carcinoma or patients with type 2 multiple endocrine neoplasms; patients with hypersensitivity to Semeglutide or any of the ingredients in this product are contraindicated; if pancreatitis is suspected,
Semeglutide should be discontinued and appropriate therapy initiated; hypoglycaemia occurs with concomitant insulinotropic agents or insulin; when severe gastrointestinal adverse reactions should be monitored when starting or increasing the dose of Somalutide; common side effects of the drug include nausea, diarrhoea, loss of appetite, abdominal pain, vomiting and constipation. Patients are advised to take the drug as prescribed by their doctor.
Note: The above information was obtained from the internet and edited by Medical Companions (please help to correct any errors or omissions), and is intended to provide information on the latest marketed drugs worldwide and to help Chinese patients understand international new drug developments.